IMNN•benzinga•
IMUNON Announces 20% Increase In IL-12 Levels In Phase 2 OVATION 2 Study Of IMNN-001 For Advanced Ovarian Cancer; Phase 3 Trial Planned
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 19, 2025 by benzinga